https://pipelinereview.com/alnylam-announces-approval-of-givlaari-givosiran-in-the-european-union-for-the-treatment-of-acute-hepatic-porphyria-ahp-in-adults-and-adolescents/
Alnylam Announces Approval of GIVLAARI® (givosiran) in the European Union for the Treatment of Acute Hepatic Porphyria (AHP) in Adults and Adolescents